Details of the Drug
General Information of Drug (ID: DM3NCM1)
Drug Name |
Alpha-D-Mannose-6-Phosphate
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
alpha-D-mannose-6-phosphate; 6-H2PO3Manalpha; alpha-D-mannose 6-phosphate; (6P)Manalpha; Man6P; (6P)Mana; 6-O-phosphono-alpha-D-mannopyranose; UNII-C77UQ006XD; C77UQ006XD; CHEBI:43896; Mannose 6-phosphate; M6P; 1syo; 1m6p; 1sz0; AC1L9KGE; SCHEMBL742653; CHEMBL402001; NBSCHQHZLSJFNQ-PQMKYFCFSA-N; ZINC4096188; DB02900; alpha-D-Mannopyranose, 6-(dihydrogen phosphate); WURCS=2.0/1,1,0/[a1122h-1a_1-5_6*OPO/3O/3=O]/1/; [(2R,3S,4S,5S,6S)-3,4,5,6-tetrahydroxyoxan-2-yl]methyl dihydrogen phosphate
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 2 | Molecular Weight (mw) | 260.14 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | -4.2 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 3 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 6 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 9 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
|||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | ||||||||||||||||||||||||||||||||